Detalhe da pesquisa
1.
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram.
Ann Oncol
; 28(3): 555-561, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864220
2.
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
Int J Cancer
; 139(12): 2859-2864, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27578417
3.
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial.
Ann Oncol
; 26(4): 724-730, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600568
4.
Current status and future perspectives in HER2 positive advanced gastric cancer.
Clin Transl Oncol
; 24(6): 981-996, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091998
5.
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program.
ESMO Open
; 7(6): 100634, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493602
6.
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience.
ESMO Open
; 7(3): 100506, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696748
7.
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM).
ESMO Open
; 7(5): 100567, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994791
8.
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.
ESMO Open
; 7(2): 100406, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219245
9.
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards.
ESMO Open
; 6(2): 100040, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33540286
10.
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumors.
Cancer Treat Rev
; 57: 28-35, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28535439
11.
Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406].
ESMO Open
; 7(2): 100471, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35378403
12.
Primary cardiac angiosarcoma: a fatal disease.
Case Rep Med
; 2009: 591512, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19724650